Tango Therapeutics (TNGX) Operating Margin (2020 - 2025)
Tango Therapeutics' (TNGX) quarterly Operating Margin came in at 26.15% in Q3 2025, up 30941.0% year-on-year from N/an in Q3 2024, and up 102.03% quarter-over-quarter from 1287.87% in Q2 2025.
Tango Therapeutics (TNGX) Operating Margin (2020 - 2025) Analysis & Trends
Tango Therapeutics' Operating Margin history runs 6 years deep, the most recent figure standing at 26.15% for Q3 2025.
- On a quarterly basis, Operating Margin rose 30941.0% year-over-year to 26.15% in Q3 2025; TTM through Mar 2026 was 206.22%, a 14964.0% increase from a year earlier, with the FY2025 full-year figure at 178.39%, up 16769.0% from the prior year.
- Operating Margin climbed to 26.15% in Q3 2025 per TNGX's latest filing, from 1287.87% in the prior quarter.
- Across five years, Operating Margin topped out at 26.15% in Q3 2025 and bottomed at 1287.87% in Q2 2025.
- The 5-year median for Operating Margin is 432.41% (2022), against an average of 440.58%.
- Biggest YoY gain for Operating Margin was 30941 bps in 2025; the steepest drop was 113918 bps in 2025.
- Year by year, Operating Margin stood at 384.6% in 2021, then slipped by 24 bps to 476.79% in 2022, then tumbled by 35 bps to 644.69% in 2023, then plunged by 54 bps to 993.68% in 2024, then soared by 103 bps to 26.15% in 2025.
- Per Business Quant, the three latest TNGX Operating Margin figures stand at 26.15% (Q3 2025), 1287.87% (Q2 2025), and 788.76% (Q1 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 16.51% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 38.10% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 17.83% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 31.68% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Tango Therapeutics | 3.94 Bn | 3.78 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 26.15% |
| Jun 30, 2025 | -1,287.87% |
| Mar 31, 2025 | -788.76% |
| Dec 31, 2024 | -993.68% |
| Sep 30, 2024 | -283.26% |
| Jun 30, 2024 | -148.69% |
| Mar 31, 2024 | -652.99% |
| Dec 31, 2023 | -644.69% |
| Sep 30, 2023 | -238.78% |
| Jun 30, 2023 | -159.25% |
| Mar 31, 2023 | -525.25% |
| Dec 31, 2022 | -476.79% |
| Sep 30, 2022 | -432.41% |
| Jun 30, 2022 | -436.70% |
| Mar 31, 2022 | -440.76% |
| Dec 31, 2021 | -384.60% |
| Sep 30, 2021 | -288.33% |
| Jun 30, 2021 | -25.10% |
| Mar 31, 2021 | -189.18% |
| Dec 31, 2020 | -2.94% |